Pediatric COVID-19 Immunization Schedules Updated with Bivalent Booster Vaccines
By: Helen Li, PharmD Candidate c/o 2023 On June 18, 2022, Centers for Disease Control and Prevention (CDC) Director,…
Rho Chi Talks: Valuable Networking Opportunities at Alumni Insider’s View
Featuring: Amanda Murray, PharmD Candidate c/o 2024 and Laura Cranston, B.S.PharmBy: Ashley Dao, PharmD Candidate c/o 2024 Alumni Insider’s View…
AstraZeneca’s Farxiga is First Heart Failure Drug to Show Across-the-Board Mortality Benefit
By: Jennifer Galvet, PharmD Candidate c/o 2024 Farxiga (dapagliflozin) is a first-in-class, oral, once daily sodium-glucose cotransporter 2 (SGLT2)…
Rectal Cancer Disappears After Use of Immunotherapy
By: Sairah Sheikh, PharmD Candidate c/o 2024 Promising new research conducted by doctors at Memorial Sloan Kettering Cancer Center…
6th Year Perspective: The Establishment of RunnersRx
Featuring: Ali Baig, PharmD Candidate c/o 2023By: Helen Li, PharmD Candidate c/o 2023 Ali Baig is a sixth-year pharmacy student…
FDA’s Approval of Pharmacists Prescribing Paxlovid
By: Imaan Sekhery, PharmD Candidate c/o 2025 On July 6, 2022, the Food and Drug Administration (FDA) revised the…
FDA Approves Tubeless Automated Insulin System for Kids 2 Years of Age and Older
By: Geraldine Ciaccio, PharmD Candidate c/o 2025 Young children with type 1 diabetes (T1D) are completely dependent on others…
New FDA Approval of Bydureon for Treating Type 2 Diabetes in Pediatric Patients
By: Kelly Lavery, PharmD Candidate c/o 2024 Increasing rates of childhood obesity remain a major risk factor behind a…
Rho Chi Talks: The Reality of an Emergency Medicine Pharmacist
Featuring: Colleen Bond, PharmD, BCPSBy: Justin Budz, PharmD Candidate c/o 2023 At a young age, Dr. Colleen Bond was involved…
Mounjaro (Tirzepatide): Dual-Targeted Treatment for Type 2 Diabetes
By: Zarin Chowdhury, PharmD Candidate c/o 2023 and Lauren Merkovich, PharmD Candidate c/o 2023 Type 2 diabetes (T2D) is…